AR201880A1 - Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol - Google Patents
Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazolInfo
- Publication number
- AR201880A1 AR201880A1 AR255045A AR25504574A AR201880A1 AR 201880 A1 AR201880 A1 AR 201880A1 AR 255045 A AR255045 A AR 255045A AR 25504574 A AR25504574 A AR 25504574A AR 201880 A1 AR201880 A1 AR 201880A1
- Authority
- AR
- Argentina
- Prior art keywords
- nitrotiazol
- benzamido
- procedure
- preparation
- new derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/58—Nitro radicals
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3760873A GB1437800A (en) | 1973-08-08 | 1973-08-08 | Derivatives of 2-benzamido-5-nitro-thiazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
AR201880A1 true AR201880A1 (es) | 1975-04-24 |
Family
ID=10397712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR255045A AR201880A1 (es) | 1973-08-08 | 1974-08-05 | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol |
Country Status (14)
Country | Link |
---|---|
US (1) | US3950351A (es) |
JP (1) | JPS5041858A (es) |
AR (1) | AR201880A1 (es) |
BE (1) | BE817878A (es) |
CA (1) | CA1041519A (es) |
CH (1) | CH583215A5 (es) |
DE (1) | DE2438037C2 (es) |
ES (1) | ES428906A1 (es) |
FR (1) | FR2240010B1 (es) |
GB (1) | GB1437800A (es) |
IL (1) | IL45194A (es) |
NL (1) | NL176779C (es) |
OA (1) | OA04761A (es) |
ZA (1) | ZA744409B (es) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2435905A1 (fr) * | 1978-09-13 | 1980-04-11 | Anvar | Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole |
US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
FI64587C (fi) * | 1979-12-21 | 1983-12-12 | Wellcome Found | Foerfarande foer framstaellning av farmaceutiskt anvaendbara 2-(substituerad-bensoyl-imino)-5-nitro-4-tiazoliner |
NZ284800A (en) * | 1994-04-13 | 1998-02-26 | Rossignol Jean Francois | 2-hydroxy-n-(5-nitro-thiazol-2-yl)-benzamide, medicaments particularly in conjunction with the acetylated form |
US5578621A (en) * | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
US5387598A (en) * | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
MX9604483A (es) * | 1994-09-08 | 1998-02-28 | Jean-Francois Rossignol | Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas. |
US5859038A (en) * | 1994-09-08 | 1999-01-12 | Romark Laboratories, L.C. | Method for treatment of helicobacter pylori infections |
US5968961A (en) * | 1997-05-07 | 1999-10-19 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
NZ500149A (en) * | 1997-05-07 | 2001-11-30 | Romark Lab L | Pharmaceutical compositions containing tizoxanide and/or nitazoxinade |
AU756451B2 (en) * | 1997-05-07 | 2003-01-16 | Romark Laboratories, L.C. | Pharmaceutical compositions of tizoxanide and nitazoxanide |
US5935591A (en) * | 1998-01-15 | 1999-08-10 | Romark Laboratories, L.C. | Method for treatment of equine protozoal myeloencephalitis with thiazolides |
US5925622A (en) * | 1998-07-13 | 1999-07-20 | Romark Laboratories, L.C. | Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
GB0325402D0 (en) * | 2003-10-31 | 2003-12-03 | Astrazeneca Ab | Compounds |
GB0327761D0 (en) * | 2003-11-29 | 2003-12-31 | Astrazeneca Ab | Compounds |
GB0328178D0 (en) * | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Compounds |
US20080280872A1 (en) * | 2004-02-18 | 2008-11-13 | Craig Johnstone | Benzamide Derivatives and Their Use as Glucokinase Activating Agents |
US20080312207A1 (en) * | 2004-02-18 | 2008-12-18 | Craig Johnstone | Compounds |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
US20060194853A1 (en) * | 2004-10-08 | 2006-08-31 | Rossignol Jean F | Alkyl benzamides |
MX2007004560A (es) | 2004-10-16 | 2007-06-08 | Astrazeneca Ab | Proceso para hacer compuestos de fenoxi benzamida. |
GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
US20070015803A1 (en) * | 2005-04-12 | 2007-01-18 | Romark Laboratories L.C. | Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
EP1891069A1 (en) * | 2005-05-24 | 2008-02-27 | AstraZeneca AB | 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
BRPI0622261A2 (pt) * | 2005-07-09 | 2011-08-09 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto |
US20080234273A1 (en) * | 2005-07-09 | 2008-09-25 | Mckerrecher Darren | Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
EP1910350A1 (en) * | 2005-07-09 | 2008-04-16 | AstraZeneca AB | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
CA2636527C (en) * | 2006-01-09 | 2016-05-17 | Romark Laboratories, L.C. | Viral hepatitis treatment |
US7678791B2 (en) * | 2006-07-12 | 2010-03-16 | Cumbre Ip Ventures, L.P. | Nitroheteroaryl-containing rifamycin derivatives |
CN100465169C (zh) * | 2006-08-02 | 2009-03-04 | 杭州欣阳三友精细化工有限公司 | 硝唑尼特的制备方法 |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
SA07280576B1 (ar) * | 2006-10-26 | 2011-06-22 | استرازينيكا ايه بي | مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز |
US20100094009A1 (en) * | 2006-12-21 | 2010-04-15 | Mccabe James | Novel crystalline compound useful as glk activator |
CN101007792B (zh) * | 2007-01-31 | 2010-05-26 | 浙江大学 | 一种合成硝基噻唑苯酰胺化合物的方法 |
CA2695517C (en) | 2007-08-03 | 2016-09-20 | J. Edward Semple | Alkylsulfonyl-substituted thiazolide compounds |
MX2011001333A (es) * | 2008-08-04 | 2011-03-15 | Astrazeneca Ab | Derivados de pirazolo [3, 4] pirimidin-4-ilo y sus usos para tratar la diabetes y obesidad. |
KR101687841B1 (ko) | 2008-12-09 | 2016-12-19 | 길리애드 사이언시즈, 인코포레이티드 | 톨-유사 수용체의 조절제 |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
US8524278B2 (en) | 2009-02-13 | 2013-09-03 | Romark Laboratories L.C. | Controlled release pharmaceutical formulations of nitazoxanide |
WO2010116176A1 (en) * | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
WO2010116177A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity |
CN105853415A (zh) | 2009-05-12 | 2016-08-17 | 罗马克实验室有限公司 | 卤代烷基杂芳基苯甲酰胺化合物 |
CA2968113C (en) | 2009-06-26 | 2019-05-14 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
CN101602744B (zh) * | 2009-06-30 | 2011-06-01 | 青岛康地恩药业有限公司 | 一种硝唑尼特的制备方法 |
US9498441B2 (en) | 2012-01-27 | 2016-11-22 | Siegfried Rhein S.A. De C.V. | Nitazoxadine composition and process to prepare same |
US20150250765A1 (en) | 2012-09-27 | 2015-09-10 | Siegfried Rhein S.A. De C.V. | Nitazoxanide and mebendazole synergic composition, processes for the preparation thereof, and use of said composition for the treatment of human parasitosis |
US20160244435A1 (en) * | 2013-06-21 | 2016-08-25 | The Scripps Research Institute | Expanded therapeutic potential in nitroheteroaryl antimicrobials |
NZ728072A (en) | 2014-07-11 | 2018-06-29 | Gilead Sciences Inc | Modulators of toll-like receptors for the treatment of hiv |
KR20190125537A (ko) | 2014-09-16 | 2019-11-06 | 길리애드 사이언시즈, 인코포레이티드 | 톨-유사 수용체 조정제의 고체 형태 |
WO2016077420A1 (en) | 2014-11-11 | 2016-05-19 | Romark Laboratories, L.C. | Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof |
CN105175352A (zh) * | 2015-10-27 | 2015-12-23 | 杭州澳医保灵药业有限公司 | 一种硝唑尼特的制备方法 |
CN106831640A (zh) * | 2015-12-03 | 2017-06-13 | 江苏正大丰海制药有限公司 | 一种硝唑尼特晶体的制备方法 |
WO2017173056A1 (en) | 2016-03-31 | 2017-10-05 | Romark Laboratories L.C. | Thiazolide compounds for treating viral infections |
EA201892298A1 (ru) | 2016-04-11 | 2019-04-30 | Женфит | Способы лечения холестатических и фибротических заболеваний |
CA3046158A1 (en) | 2017-01-27 | 2018-08-02 | Genfit | Pharmaceutical compositions for combination therapy |
US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
EP3952869A1 (en) | 2019-04-12 | 2022-02-16 | Genfit | Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stress |
EP4051257A1 (en) | 2019-10-28 | 2022-09-07 | Genfit | Combination therapy having antioxydant properties |
EP4182304A1 (en) | 2020-07-20 | 2023-05-24 | Romark Laboratories, L.C. | Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine |
WO2022046622A1 (en) | 2020-08-24 | 2022-03-03 | Romark Laboratories L.C. | Use of thiazolides against coronaviruses |
CN114044761B (zh) * | 2021-02-24 | 2022-05-17 | 成都贝诺科成生物科技有限公司 | 一种新的硝基噻唑衍生物及其应用 |
CN115197164A (zh) * | 2021-04-12 | 2022-10-18 | 杜心赟 | 新型噻唑类化合物及其制备方法和用途 |
WO2023198095A1 (zh) * | 2022-04-12 | 2023-10-19 | 成都贝诺科成生物科技有限公司 | 一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2829084A (en) * | 1958-04-01 | Certain alkyl-n | ||
CA497537A (en) * | 1953-11-10 | H. Clark Joe | 2-substituted amino-5-nitrothiazoles | |
US2735798A (en) * | 1956-02-21 | Acyl amevo-nitrothiazole compositions | ||
US2401522A (en) * | 1942-04-17 | 1946-06-04 | Firm Sandoz Ltd | Aromatic carboxylic acid amides and a process for their manufacture |
GB577418A (en) * | 1942-04-17 | 1946-05-17 | Sandoz Ltd | Process for the preparation of amides of aromatic carboxylic acids |
FR1306603A (fr) * | 1958-08-14 | 1962-10-19 | Innothera Lab Sa | Dérivés thiazoliques et leur procédé de préparation |
US3475446A (en) * | 1967-06-27 | 1969-10-28 | Parke Davis & Co | N-(5-nitro-2-thiazolyl)-cycloalkanecarboxamides |
-
1973
- 1973-08-08 GB GB3760873A patent/GB1437800A/en not_active Expired
-
1974
- 1974-07-03 IL IL45194A patent/IL45194A/en unknown
- 1974-07-09 ZA ZA00744409A patent/ZA744409B/xx unknown
- 1974-07-10 NL NLAANVRAGE7409321,A patent/NL176779C/xx not_active IP Right Cessation
- 1974-07-19 BE BE146759A patent/BE817878A/xx not_active IP Right Cessation
- 1974-07-23 CA CA205,468A patent/CA1041519A/en not_active Expired
- 1974-07-23 JP JP49083868A patent/JPS5041858A/ja active Pending
- 1974-08-02 ES ES428906A patent/ES428906A1/es not_active Expired
- 1974-08-05 AR AR255045A patent/AR201880A1/es active
- 1974-08-07 DE DE2438037A patent/DE2438037C2/de not_active Expired
- 1974-08-07 CH CH1083074A patent/CH583215A5/xx not_active IP Right Cessation
- 1974-08-08 US US05/495,749 patent/US3950351A/en not_active Expired - Lifetime
- 1974-08-08 FR FR7427525A patent/FR2240010B1/fr not_active Expired
- 1974-08-08 OA OA55271A patent/OA04761A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA1041519A (en) | 1978-10-31 |
FR2240010A1 (es) | 1975-03-07 |
JPS5041858A (es) | 1975-04-16 |
ZA744409B (en) | 1975-07-30 |
AU7135574A (en) | 1976-01-22 |
NL176779B (nl) | 1985-01-02 |
BE817878A (fr) | 1975-01-20 |
US3950351A (en) | 1976-04-13 |
NL176779C (nl) | 1985-06-03 |
DE2438037C2 (de) | 1982-06-09 |
IL45194A0 (en) | 1974-10-22 |
ES428906A1 (es) | 1976-08-16 |
GB1437800A (en) | 1976-06-03 |
DE2438037A1 (de) | 1975-02-20 |
CH583215A5 (es) | 1976-12-31 |
NL7409321A (nl) | 1975-02-11 |
IL45194A (en) | 1977-10-31 |
FR2240010B1 (es) | 1978-03-24 |
OA04761A (fr) | 1980-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR201880A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2-benzamido-5-nitrotiazol | |
AR207133A1 (es) | Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano | |
MX152550A (es) | Procedimiento para la preparacion de derivados de fenilnonatetraenos substituidos | |
AR202617A1 (es) | Procedimiento para la preparacion de metitioetilclanoguanidinas heterociclicas | |
MX4592E (es) | Procedimiento para la preparacion de 1-ariloxi-2-hidroxi-3-alquinilaminopropanos | |
AR210725A1 (es) | Procedimiento para la preparacion de derivados de dibenzoxepina | |
MX3765E (es) | Procedimiento para la preparacion de derivados de piperidina | |
MX5768E (es) | Procedimiento para la preparacion de derivados del alpha-etil-benzhidrol | |
AR203188A1 (es) | Procedimiento para la preparacion de derivados de tienotriazolodiacepina | |
AR203653A1 (es) | Procedimiento para la obtencion de derivados de 3,4-dihidro-2h-naftalinona-(1)-5-oxi-propil-piperazina | |
AR207022A1 (es) | Procedimiento para la preparacion de poli-n-dimetiliminoalano | |
AR207744A1 (es) | Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas | |
AR206632A1 (es) | Procedimiento para la preparacion de d-homoesteroides | |
AR208187A1 (es) | Metodo para la preparacion derivados de n-carbamoil-2-feniletensulfonamida | |
AR203196A1 (es) | Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima | |
AR200441A1 (es) | Procedimiento para la obtencion de nuevos derivados de alfa-l-arabinosido de digitoxigenina | |
AR210133A1 (es) | Procedimiento para preparar nuevos derivados de 3-amino-5-metil-pirrol | |
AR207450A1 (es) | Procedimiento para la produccion de derivados de 4-fenilsulfonil-metil-prehidroindan-5-onas | |
AR205800A1 (es) | Procedimiento para la preparacion de nuevos derivados de 3,4-difenil-imidazolina | |
AR207633Q (es) | Procedimiento para la elaboracion de nuevos derivados de 2-benzoil-3-amino-6-cloro-piridinas | |
AR206653A1 (es) | Procedimiento para preparar nuevos derivados de n-aminoalquil-2-amino-indano | |
AR209616A1 (es) | Procedimiento para la preparacion de derivados de 17alpha-aciloxi-d-homo-pregn-4-eno-3,20-diona | |
AR211695A1 (es) | Procedimiento para la preparacion de derivados de aminoscilanilidas primarias | |
AR202848A1 (es) | Procedimiento para la preparacion de derivados de triazolobenzodiacepinas | |
AR201032A1 (es) | Un procedimiento para la preparacion de derivados de 5-feniltienodiazepinona |